Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Infrastructure nationale du savoir de Chine (CNKI)
  • Bibliothèque de revues électroniques
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Bibliothèque virtuelle de biologie (vifabio)
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

Perspectives of HCC-Treating Clinicians: Identifying Facilitators and Barriers to Palliative Care Referral for Individuals with Hepatocellular Carcinoma

James Baker

The referral of individuals with hepatocellular carcinoma (HCC) to palliative care remains a complex and underexplored area. This study aims to identify the factors that either promote or hinder palliative care referral as reported by clinicians treating patients with HCC. Through the development of a comprehensive code book, all interviews were coded using axial coding, with selective coding employed to pinpoint facilitators and barriers of palliative care referral. The identified facilitators included the invaluable support during transitions, assistance in managing specific symptoms, provision of psychosocial support, and positive past experiences with palliative care referrals. On the other hand, barriers encompassed concerns about feasibility, limited knowledge about palliative care and suitable candidates, absence of symptoms necessitating external referral, and fears that palliative care might be perceived as a sign of hopelessness. Participants recognized the benefits of palliative care at certain stages of the disease trajectory while also identifying barriers related to feasibility, perceived lack of need, limited awareness, and concerns about hopelessness. These findings provide actionable insights for future research to enhance the advantages of palliative care and address obstacles for individuals with HCC effectively.